To diet or not if you have inflammatory bowel disease

References

• Sandler RS, Everhart JE, Donowitz M et al. The burden of selected digestive diseases in the United States. Gastroenterology122(5), 1500–1511 (2002).
   PubMed Web of Science ®Google Scholar
• Kucharzik T, Maaser C, Lügering A et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm. Bowel. Dis.12(11), 1068–1083 (2006).
   PubMed Web of Science ®Google Scholar
• McDonald PJ, Fazio VW. What can Crohn’s patients eat? Eur. J. Clin. Nutr.42(8), 703–708 (1988).
   PubMedGoogle Scholar
• Jones VA, Dickinson RJ, Workman E, Wilson AJ, Freeman AH, Hunter JO. Crohn’s disease: maintenance of remission by diet. Lancet2(8448), 177–180 (1985).
   PubMed Web of Science ®Google Scholar
• Moser G, Tillinger W, Sachs G et al. Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease. J. Psychosom. Res.40(5), 503–509 (1996).
   PubMed Web of Science ®Google Scholar
• King TS, Woolner JT, Hunter JO. Dietary treatment of active Crohn’s disease. Diet is the best treatment. BMJ314(7097), 1827–1828 (1997).
   PubMedGoogle Scholar
• King TS, Woolner JT, Hunter JO. Review article: the dietary management of Crohn’s disease. Aliment. Pharmacol. Ther.11(1), 17–31 (1997).
   PubMedGoogle Scholar
• Mucida D, Park Y, Kim G et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science317(5835), 256–260 (2007).
   PubMed Web of Science ®Google Scholar
• Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med.204(8), 1765–1774 (2007).
   PubMed Web of Science ®Google Scholar
• Sun CM, Hall JA, Blank RB et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med.204(8), 1775–1785 (2007).
   PubMed Web of Science ®Google Scholar
• Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med.204(8), 1757–1764 (2007).
   PubMed Web of Science ®Google Scholar
• Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol. Endocrinol.17(12), 2386–2392 (2003).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Mahon BD. D-hormone and the immune system. J. Rheumatol.76(Suppl.), 11–20 (2005).
   Google Scholar
• Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood)229(11), 1136–1142 (2004).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr.130(11), 2648–2652 (2000).
   PubMed Web of Science ®Google Scholar
• Lerner A. Aluminum is a potential environmental factor for Crohn’s disease induction: extended hypothesis. Ann. NY Acad. Sci.1107, 329–345 (2007).
   PubMedGoogle Scholar
• Kliewer SA, Sundseth SS, Jones SA et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl Acad. Sci. USA94(9), 4318–4323 (1997).
   PubMed Web of Science ®Google Scholar
• Roy N, Barnett M, Knoch B, Dommels Y, McNabb W. Nutrigenomics applied to an animal model of inflammatory bowel diseases: transcriptomic analysis of the effects of eicosapentaenoic acid- and arachidonic acid-enriched diets. Mutat. Res.622(1–2), 103–116 (2007).
   PubMedGoogle Scholar
• Nam NH. Naturally occurring NF-κB inhibitors. Mini Rev. Med. Chem.6(8), 945–951 (2006).
   PubMed Web of Science ®Google Scholar
• Guarner F. Prebiotics in inflammatory bowel diseases. Br. J. Nutr.98(Suppl. 1), S85–S89 (2007).
   Google Scholar
• Turck D, Feste AS, Lifschitz CH. Age and diet affect the composition of porcine colonic mucins. Pediatr. Res.33(6), 564–567 (1993).
   PubMed Web of Science ®Google Scholar
• Salyers AA, Palmer JK, Wilkins TD. Degradation of polysaccharides by intestinal bacterial enzymes. Am. J. Clin. Nutr.31(10 Suppl.), S128–S130 (1978).
   PubMed Web of Science ®Google Scholar
• Amit-Romach E, Uni Z, Cheled S, Berkovich Z, Reifen R. Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet. J. Nutr. Biochem. DOI: 10.1016/j.jnutbio.2008.01.002 (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Onderdonk AB. The carrageenan model for experimental ulcerative colitis. Prog. Clin. Biol. Res.186, 237–245 (1985).
   PubMedGoogle Scholar
• García-Lafuente A, Antolín M, Guarner F, Crespo E, Malagelada JR. Modulation of colonic barrier function by the composition of the commensal flora in the rat. Gut48(4), 503–507 (2001).
   PubMed Web of Science ®Google Scholar
• Wang X, Brown IL, Khaled D, Mahoney MC, Evans AJ, Conway PL. Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules. J. Appl. Microbiol.93(3), 390–397 (2002).
   PubMed Web of Science ®Google Scholar
• Blaut M. Relationship of prebiotics and food to intestinal microflora. Eur. J. Nutr.41(Suppl. 1), I11–I16 (2002).
   PubMedGoogle Scholar
• Annese V, Valvano MR, Palmieri O, Latiano A, Bossa F, Andriulli A. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J. Gastroenterol.12(23), 3636–3644 (2006).
   PubMed Web of Science ®Google Scholar
• Ferguson LR, Shelling AN, Browning BL, Huebner C, Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res.622(1,2), 70–83 (2007).
   PubMed Web of Science ®Google Scholar